Literature DB >> 18951844

The molecular basis of allergenicity.

Farouk Shakib1, Amir M Ghaemmaghami, Herb F Sewell.   

Abstract

Allergens are mostly innocuous antigens that elicit powerful T helper cell type 2 (Th2) responses leading to hyper-immunoglobulin E (IgE) production and allergy. Research carried out over several years has highlighted the possible role of the inherent protease activity, surface features and glycosylation patterns of allergens in the engagement of a Th2 signalling pathway. It is thought that allergens possess common features and patterns that enable them to be recognized by innate immune defences as Th2-inducing antigens. These events are further amplified by proteolytically active allergens through digestion of cell surface molecules involved in regulating innate and adaptive immune functions, favouring Th2 responses. A greater understanding of the molecular features that make proteins allergenic will help define new therapeutic targets aimed at blocking allergen recognition and protease activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951844     DOI: 10.1016/j.it.2008.08.007

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  42 in total

1.  Molecular determinants for antibody binding on group 1 house dust mite allergens.

Authors:  Maksymilian Chruszcz; Anna Pomés; Jill Glesner; Lisa D Vailes; Tomasz Osinski; Przemyslaw J Porebski; Karolina A Majorek; Peter W Heymann; Thomas A E Platts-Mills; Wladek Minor; Martin D Chapman
Journal:  J Biol Chem       Date:  2011-12-30       Impact factor: 5.157

Review 2.  Endolysosomal proteases and their inhibitors in immunity.

Authors:  Phillip I Bird; Joseph A Trapani; José A Villadangos
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

3.  Cockroach allergen serine proteinases: Isolation, sequencing and signalling via proteinase-activated receptor-2.

Authors:  D J Polley; K Mihara; R Ramachandran; H Vliagoftis; B Renaux; M Saifeddine; M O Daines; S Boitano; M D Hollenberg
Journal:  Clin Exp Allergy       Date:  2017-04-27       Impact factor: 5.018

4.  Generation of a chimeric dust mite hypoallergen using DNA shuffling for application in allergen-specific immunotherapy.

Authors:  Bei-Bei Zhao; Ji-Dong Diao; Zhi-Ming Liu; Chao-Pin Li; Yu-Xin Jiang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  The protease allergen Pen c 13 induces allergic airway inflammation and changes in epithelial barrier integrity and function in a murine model.

Authors:  Jui-Chieh Chen; Jiing-Guang Chuang; Yu-Yi Su; Bor-Luen Chiang; You-Shuei Lin; Lu-Ping Chow
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

6.  The role of anti-CCD antibodies in grape allergy diagnosis.

Authors:  Reza Falak; Mojtaba Sankian; Hanieh Ketabdar; Malihe Moghadam; Abdol-Reza Varasteh
Journal:  Rep Biochem Mol Biol       Date:  2013-04

Review 7.  100 Years later: Celebrating the contributions of x-ray crystallography to allergy and clinical immunology.

Authors:  Anna Pomés; Maksymilian Chruszcz; Alla Gustchina; Wladek Minor; Geoffrey A Mueller; Lars C Pedersen; Alexander Wlodawer; Martin D Chapman
Journal:  J Allergy Clin Immunol       Date:  2015-07       Impact factor: 10.793

Review 8.  New insights into ragweed pollen allergens.

Authors:  Véronique Bordas-Le Floch; Rachel Groeme; Henri Chabre; Véronique Baron-Bodo; Emmanuel Nony; Laurent Mascarell; Philippe Moingeon
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

9.  Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity.

Authors:  Noah W Palm; Rachel K Rosenstein; Shuang Yu; Dominik D Schenten; Esther Florsheim; Ruslan Medzhitov
Journal:  Immunity       Date:  2013-10-24       Impact factor: 31.745

Review 10.  New insights into innate immune mechanisms underlying allergenicity.

Authors:  M Wills-Karp; A Nathan; K Page; C L Karp
Journal:  Mucosal Immunol       Date:  2009-12-23       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.